Last reviewed · How we verify

NCT06089694

Crome/Cobalt Respiration Study

Completed Last updated 15 August 2024
What this trial tests

trial testing Enabling Sensor Research Holter Mode feature in Heart Failure in 61 participants. Completed in 12 June 2024.

Timeline
21 November 2023
Primary endpoint
12 June 2024
12 June 2024

Quick facts

Lead sponsorMedtronic Cardiac Rhythm and Heart Failure
StatusCompleted
Study typeOBSERVATIONAL
Enrollment61
Start date21 November 2023
Primary completion12 June 2024
Estimated completion12 June 2024
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medtronic Cardiac Rhythm and Heart Failure — full company profile →

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to compare measured respiration rates in various subject scenarios and use conditions between capnography and the Crome and Cobalt ICD and CRT-D MRI SureScan devices (derived using a Holter recorder).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

Other Medtronic Cardiac Rhythm and Heart Failure trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06089694.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing